These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 16230385

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Dimerization of MLL fusion proteins and FLT3 activation synergize to induce multiple-lineage leukemogenesis.
    Ono R, Nakajima H, Ozaki K, Kumagai H, Kawashima T, Taki T, Kitamura T, Hayashi Y, Nosaka T.
    J Clin Invest; 2005 Apr; 115(4):919-29. PubMed ID: 15761502
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Persistent transactivation by meis1 replaces hox function in myeloid leukemogenesis models: evidence for co-occupancy of meis1-pbx and hox-pbx complexes on promoters of leukemia-associated genes.
    Wang GG, Pasillas MP, Kamps MP.
    Mol Cell Biol; 2006 May; 26(10):3902-16. PubMed ID: 16648484
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The PAF complex synergizes with MLL fusion proteins at HOX loci to promote leukemogenesis.
    Muntean AG, Tan J, Sitwala K, Huang Y, Bronstein J, Connelly JA, Basrur V, Elenitoba-Johnson KS, Hess JL.
    Cancer Cell; 2010 Jun 15; 17(6):609-21. PubMed ID: 20541477
    [Abstract] [Full Text] [Related]

  • 32. Leukaemia lineage specification caused by cell-specific Mll-Enl translocations.
    Cano F, Drynan LF, Pannell R, Rabbitts TH.
    Oncogene; 2008 Mar 20; 27(13):1945-50. PubMed ID: 17906700
    [Abstract] [Full Text] [Related]

  • 33. The oncoprotein MLL-ENL disturbs hematopoietic lineage determination and transforms a biphenotypic lymphoid/myeloid cell.
    Zeisig BB, García-Cuéllar MP, Winkler TH, Slany RK.
    Oncogene; 2003 Mar 20; 22(11):1629-37. PubMed ID: 12642866
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. EVI1 is critical for the pathogenesis of a subset of MLL-AF9-rearranged AMLs.
    Bindels EM, Havermans M, Lugthart S, Erpelinck C, Wocjtowicz E, Krivtsov AV, Rombouts E, Armstrong SA, Taskesen E, Haanstra JR, Beverloo HB, Döhner H, Hudson WA, Kersey JH, Delwel R, Kumar AR.
    Blood; 2012 Jun 14; 119(24):5838-49. PubMed ID: 22553314
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. MLL-ENL cooperates with SCF to transform primary avian multipotent cells.
    Schulte CE, von Lindern M, Steinlein P, Beug H, Wiedemann LM.
    EMBO J; 2002 Aug 15; 21(16):4297-306. PubMed ID: 12169632
    [Abstract] [Full Text] [Related]

  • 39. Targeted down-regulation of MLL-AF9 with antisense oligodeoxyribonucleotide reduces the expression of the HOXA7 and -A10 genes and induces apoptosis in a human leukemia cell line, THP-1.
    Kawagoe H, Kawagoe R, Sano K.
    Leukemia; 2001 Nov 15; 15(11):1743-9. PubMed ID: 11681416
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.